Breast Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

What's New

Last Posted: Jul 13, 2017

---

• Take Action to Lower Your Breast and Ovarian Cancer Risk  
• Current condition of genetic medicine for hereditary breast cancer.  
  Terui-Kohbata Hiroko et al. Molecular and clinical oncology 2017 Jul 7(1) 98-102
• Influence of the Angelina Jolie Announcement and Insurance Reimbursement on Practice Patterns for Hereditary Breast Cancer.  
  Lee Jihyoun et al. Journal of breast cancer 2017 Jun 20(2) 203-207
• The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapy.  
  MacDonald Karen V et al. European journal of cancer (Oxford, England : 1990) 2016 Jul 6185-93
• Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?  
  Partridge Ann H et al. Breast cancer research and treatment 2017 Jun
• Test gives accurate prognosis for breast cancer patients with 'ultralow' risk  
  A Sandou, Medical News Today, June 30, 2017
• Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades.  
  Esserman Laura J et al. JAMA oncology 2017 Jun
• Test gives accurate prognosis for breast cancer patients with 'ultralow' risk  
  A Sandou, Medical News Today, June 30, 2017
• Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades  
  LJ Esserman et al., JAMA Oncology, June 28, 2017
• Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.  
  Thakur Sunitha B et al. Journal of magnetic resonance imaging : JMRI 2017 Jun